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Weight loss is a public health concern in obesity-related diseases such as metabolic syn-
drome (MetS). However, restrictive diets might induce bone loss. The nature of exercise
and whether exercise with weight loss programs can protect against potential bone mass
deficits remains unclear. Moreover, compliance is essential in intervention programs. Thus,
we aimed to investigate the effects that modality and exercise compliance have on bone
mineral content (BMC) and density (BMD).
Methods
We investigated 90 individuals with MetS who were recruited for the 1-year RESOLVE trial.
Community-dwelling seniors with MetS were randomly assigned into three different modali-
ties of exercise (intensive resistance, intensive endurance, moderate mixed) combined with
a restrictive diet. They were compared to 44 healthy controls who did not undergo the
intervention.
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Results
This intensive lifestyle intervention (15–20 hours of training/week + restrictive diet) resulted
in weight loss, body composition changes and health improvements. Baseline BMC and
BMD for total body, lumbar spine and femoral neck did not differ between MetS groups and
between MetS and controls. Despite changes over time, BMC or BMD did not differ between
the three modalities of exercise and when compared with the controls. However, indepen-
dent of exercise modality, compliant participants increased their BMC and BMD compared
with their less compliant peers. Decreases in total body lean mass and negative energy bal-
ance significantly and independently contributed to decreases in lumbar spine BMC.
Conclusion
After the one year intervention, differences relating to exercise modalities were not evident.
However, compliance with an intensive exercise program resulted in a significantly higher
bone mass during energy restriction than non-compliance. Exercise is therefore beneficial




Most metabolic diseases are linked to excess weight or obesity [1]. All appropriate treatments
involving weight loss therapy currently include a restrictive diet. However, restrictive diet may
induce bone loss [2,3]. Bone loss accompanying body weight reduction remains debatable
[4,5,6,7]. Variable results depend on age, gender and lifestyle: physical activity [8], and protein
[4] or calcium intake [9] of individuals striving for weight loss. There is a growing consensus
that the risk of bone loss [10] is independent of the severity of dieting, as well as the amount of
body weight lost [11,12].
Discussions of the mechanisms for bone loss in weight loss programs have included the
potential for a reduction of mechanical loading combined with a lack of calcium and energy
intake [2], altered local bone cells interaction [13] and/or reduced expression of transcription
factors influencing osteoblastogenesis [14]. Moreover, energy restriction can alter the plasma
concentration of hormones involved in bone metabolism and increase the bone turnover in
obese woman [15].
The specificity of metabolic syndrome (MetS) [16] tends to target obesity at an abdominal
location [16]. Abdominal fat tissue produces numerous adipokines linked with inflammation
[17]. Therefore, during lifestyle intervention, inflammatory effects from abdominal fat tissue
may occur despite body weight reduction [18].
The benefits of weight-bearing physical activity on bone mineral content (BMC) and density
(BMD) are well established [19], and as such, exercise training may also attenuate the decrease
in BMD during a weight loss [7,20]. Nonetheless, there are conflicting reports on whether exer-
cise accompanying a weight loss program is able to protect against a potential bone loss. Both
diet-induced and exercise-induced weight loss have been linked to bone deficits [21]. Indeed,
the bones’ response to weight loss combined with exercise could be specific to weight-bearing
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sites. Moreover, compliance with physical activity and dietary guidelines has been reported to
be essential in the success of lifestyle interventions [22].
The RESOLVE trial (REverse metabolic SyndrOme by Lifestyle and Various Exercises) is an
interventional study that assessed the change in elderly participants with MetS after one year
[23]. It aimed to compare the broad health-related effects of three different modalities of exer-
cise (intensive resistance, intensive endurance, and moderate mixed) combined with a restric-
tive diet. This intensive lifestyle intervention resulted in weight loss, body composition changes
and improvement of participants’ health [23,24]. To understand more about associated bone
changes we also assessed BMC and BMD at each step of the intervention.
Multilevel statistical models are appropriate to deal with repeated measurements. Therefore,
the purpose of the present study was to determine the effects of weight loss and the associated
characteristics of MetS on bone metabolism, taking into account a physical activity program
implementing three different modalities of exercise. If physical activity was capable of compen-
sating for the bone loss induced by the restrictive diet, we further investigated whether any spe-
cific modality of exercise induced a better result than the others. A second purpose was to
assess the effects of compliance to diet and exercise by measuring the observance of partici-
pants during a 3-week residential program followed by 11 months of at-home intervention.
Methods
Participants
Volunteers were recruited via advertisements. They gave their written informed consent. The
study was reviewed and approved by the human research ethics committee from the University
Hospital of St Etienne, France. To be eligible, participants had to be: aged between 50 and 70
years, symptomatic of MetS [16], leading a sedentary lifestyle, stable in body weight and medi-
cal treatment over the previous 6 months, post-menopausal for women, without hepatic, renal,
or psychiatric diseases, nor cardiovascular or endocrine diseases except those defining MetS,
devoid of medications altering bone tissue properties, not undertaking restrictive dieting in the
previous year, and able to complete a normal maximal exercise tolerance test (VO2max).
For baseline references, data were obtained from an age-matched control group of healthy
participants who did not undergo any intervention. Criteria for inclusion as a healthy control
included being without any of the defined criteria of MetS, chronic disease, and routine medi-
cation. They also had to report a stable lifestyle over the previous 12 months, and at the time of
testing were completing less than three hours of organized physical activity per week.
Primary outcome
The primary outcome was the change in BMC and BMD for the whole body, lumbar spine and
non-dominant hip. BMC and BMD were measured by dual-energy X-ray absorptiometry scans
(DXA, Hologic QDR 4500 series; Waltham, USA). The in-vivo coefficient of variation (CV)
was 0.5%.
Secondary outcomes
Anthropometry. Body height was measured with a standard stadiometer (Holtain, Ltd.,
Crymych, UK). Fat mass and lean body mass were measured by DXA, with respective in vivo
CV of 4.2 and 0.4%. Central fat, a surrogate of visceral fat, was assessed from DXA scans, as
described by Kamel et al [25]. We determined a CV of 1.6% in the central fat measurements.
Biochemistry. Fasting blood samples were drawn between 7.00 and 7.30 a.m., aliquoted
and stored at -80°C until analysis. Basic biological assays were performed in the biochemistry
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laboratory of the University Hospital of Clermont-Ferrand, France. Insulin, pro-inflammatory
cytokines (TNF-alpha, IL-1 and IL-6), the adipokines leptin and adiponectin, and PAI-1 were
assayed by ELISA using commercial kits (Millipore, Billerica, MA, USA). Sensitivity, intra-
and interassay coefficients of variation were respectively 3.0 ng/ml, 2.6%, 7.2% for insulin;
0.7 pg/ml, 6.0% and 9.0%, for TNF-alpha; 1.3 pg/ml, 9.0% and 9.0% for IL-1; 1.3 pg/ml, 7.0%
and 10.0% for IL-6; 0.16 ng/ml, 5.1% and 7.4% for leptine; 0.78 ng/ml, 0.9% and 2.4% for adi-
ponectine; 1.3 pg/ml, 6.6% and 10% for active PAI-1 and total PAI-1. Insulin resistance was
estimated by calculating of the homeostasis model assessment-insulin resistance (HOMA-IR)
index (fasting plasma glucose x fasting plasma insulin)/22.5. Bone metabolism markers
included the serum concentration of osteocalcin, which was assayed by ELISA (N-MID Osteo-
calcin ELISA, Nordic Bioscience Diagnostics A/S, Denmark). Intra- and interassay CVs were
2.6% and 4.7%, respectively, with a sensitivity of 0.5 ng/ml. Other bone metabolism markers
were Procollagen type I N-terminal propeptide (PINP) and type I-C telopeptide breakdown
products (CTX) which were assayed using Cobas 6000 (Roche Diagnostic, Mannheim, Ger-
many) with intra and inter-assay CVs lower than 7%.
Exercise and nutrition. Three-day self-report questionnaires on food intake and physical
activity allowed the calculation of daily energy intake and daily energy expenditure, as well as
daily calcium and protein intake. Routine medications were recorded and all participants were
advised to maintain their baseline medications.
Time of measurements
Outcomes were measured at baseline (Day 0), 21 days (D21), 3 months (D90), 6 months
(D180) and 12 months (D360), with the exception of bone biomarkers which were measured at
D0, D21, and D180. Self-reported questionnaires on food intake and physical activity were
completed each month.
Randomization
Stratified computer-generated randomization (combined with permuted blocks to produce
balanced allocation within each stratum) was used to account for sex, age, and body mass
index, then participants were assigned to one of the following groups:
- Re: high-Resistance-moderate-endurance, 10 repetitions performed at 70% of one maximal
repetition for resistance and 30% of VO2-peak for endurance training,
- rE: moderate-resistance (30%)-high-Endurance (70%),
- re: moderate-resistance (30%)-moderate-endurance (30%).
Sex was incorporated as a dummy coded variable. Baseline age was divided at the median
(60.8 years and>60.8 years) and BMI at the tertiles (30.6 kg.m-2, 30.7 to 36.6 kg.m-2, and
>36.6 kg.m-2) were also applied to stratification. Based on the number and levels of stratifica-
tion factors, 12 strata were considered with1% risk of a value smaller than 3 participants per
stratum [26].
All participants followed the same restrictive diet. Assessors for all outcomes were blinded
to the participants’ group assignment. All outcome data remained blinded until the completion
of the intervention.
First stage of intervention: A 3-week residential program
Each day, throughout the residential program, the patients received both standard and person-
alized balanced meals prescribed by dieticians. Protein accounted for 15 to 20% of the total
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energy intake (1.2 g.kg-1.day-1 to maintain protein homeostasis) [27], 30 to 35% were lipids,
and carbohydrates comprised the remaining composition of the food groups. Participants’
total daily food intake was calculated to enable them to reach a negative energy balance of
~2090 kJ per day (i.e. 500 kcal per day). Participants were individually coached on daily basis,
within the context of their assigned group. An equal amount of time (15–20 h/week) was spent
by all groups in endurance (90 min daily) and in resistance (90 min, four days a week). Exer-
cises differed only in intensity, from 30% to 70%. Participants’ heart rates were monitored by
Polar S810 with instantaneous recording and storage of heart rate values. Endurance training
included aquagym, cycling and walking. Resistance training consisted of 8 exercises with free
weights and traditional muscle building equipment. Each exercise was performed for three sets
of 10 repetitions.
Second stage of intervention: A 1-year at-home follow-up
From D21 to D360, the participants were required to complete the same training program
without supervision. At D90, D180 and D360, the participants were seen by the dietician and a
physical coach for individual adjustments to their program.
A compliance score was determined on the basis of the number of food questionnaires
returned (score from 0 to 12 i.e. 12 = 100%) and the number of training sessions undertaken
per week (score from 0 to 4, i.e. 4 = 100%). The overall compliance score was the mean of these
two scores (nutrition and physical activity). The participants who reached a score of 60% and
over were considered as compliant.
Statistical analysis
The number of participants for each group was based upon the amount of expected central fat
loss [23]. A sample of 30 participants per intervention group allowed a statistical power greater
than 80% with an α level less than 5%, allowing a dropout rate of 20%.
Descriptive results are presented as means ± standard deviation (SD) unless otherwise
noted. The Gaussian distribution for each parameter was assessed by a Shapiro-Wilk test. In
case of non-normal distribution, data were log-transformed for analysis. Baseline and follow-
up characteristics were cross-sectionally compared between groups using analysis of variance
(ANOVA). Alpha levels were set at 0.05 and were adjusted using the Bonferroni technique for
multiple comparisons; for example, for 10 comparisons, the α corrected for experiment-wise
error rate would be 0.05/10 = 0.005. All these routine analyses were assessed using SPSS soft-
ware v19.0 (IBM Company, NY, USA).
For the analysis of the change, taking into account the multilevel design of the program
[level 1 units (individuals stratified by age, sex and body mass index) within each level 2 unit
(individuals of different MetS groups)], hierarchical random effects models (REM) were con-
structed using a multilevel modeling approach (MLwiN v2.26, Center for Multilevel Modelling,
University of Bristol, Bristol, UK) [28]. Analysis models that contained variables measured at
different levels of a hierarchy are known as multilevel regression models. The following addi-
tive polynomial multilevel model was adopted to describe the changes in BMC and in BMD
from study entry:
yij ¼ ða þ mjÞ þ ðb þ vjÞ xij þ ðɀ1ij þ ɀ2ij þ    þ ɀnijÞ þ εij
This equation is an example of REM in which level 1 regression coefficients are treated as
random variables at level 2. In this example, the number of days from baseline (x) is in both the
fixed and random parts of the model. This is seen clearly when equation 1 is rearranged into
Multilevel Approach of a 1-Year Lifestyle Intervention on Bone in MetS
PLOS ONE | DOI:10.1371/journal.pone.0136491 September 16, 2015 5 / 20
fixed and random parts:
yij ¼ ða þ bj xij Þ þ ðɀ1ij þ ɀ2ij þ    þ ɀnijÞ þ ðmj þ vj xij þ εijÞ
where y is the bone parameter [BMC (g) or BMD (g/cm2)] on measurement occasion i in the
jth individual, α is the constant for each jth individual, βj xij is the slope for the bone parameter
over time (in these models, the number of days from baseline was centered around day 180,
the middle time point of the study) for the jth individual; and ɀ1 to ɀn were the coefficients of
explanatory variables (e.g., intervention group, total body lean mass, vitamin D, etc.) at assess-
ment occasion i in the jth individual [28,29]. These were the fixed parameters in the model.
Both μj, vjxij and εij formed the random parameters in the model. They were assumed to be
independent and follow a normal distribution, with means equal to zero and variance σ2. εij~N
[0,var(εij)] was the level 1 residual (within-individual variance) for the ith assessment of BMC
(g) or BMD (g/cm2) in the jth individual. Also, μj~N[0,var(μ)] was the between-individuals’
intercept variance and vijxij~N[0,var(vijxij)] was the between-individuals’ slope variance; thus
being used as the level 2 residuals (between subjects) variances for the jth individual. The equa-
tion μj×vijxij~N[0,var(μj×vijxij)] explained the intercept-slope covariance relationships among
the intercepts and slopes in the model [28,29].
Models were built using a stepwise procedure, i.e. predictor variables (z fixed effects) were
added one at a time, and likelihood ratio statistics were used to judge the statistical fit of the
model [28]. Predictor variables (z) were accepted as significant if the estimated mean coeffi-
cient was greater than twice the standard error of the estimate. If the retention criterion was
not met, the predictor variable was discarded. Power functions for the number of days from
baseline were introduced into the linear models to allow for the nonlinearity of changes in
bone parameters. Based on analytical [i.e., Pearson’s product moment correlation coefficients
(ry,x) between bone parameters (y) and potential predictors (x) at baseline, D21, D90, D180
and D360] and biological assumptions, the following variables were considered in the multi-
level models: days from baseline, days from baseline2, age at study start, total body lean mass,
total body fat mass, central fat mass, energy intake, protein, calcium, vitamin D, CRP, hsCRP
and leptin. Dummy variables were created for MetS, sex and compliance groups with re partici-
pants, female participants and non-compliant participants as the respective reference catego-
ries. Neither insulin, HOMA-IR, pro-inflammatory cytokines (TNF-alpha, IL-1 and IL-6),
adiponectin, active and total PAI-1, nor bone metabolism markers (osteocalcin, PINP, and
CTX) were significantly related with bone parameters at any measurement occasion, thus they
were discarded from the multilevel analysis. A tolerance> 0.10 and a variance inflation
factor< 10 were set to avoid collinearity between explanatory variables [30]. A total of six
independent multilevel REMs were constructed, specifically: whole body BMC, lumbar spine
BMC, femoral neck BMC, whole body BMD, lumbar spine BMD, and femoral neck BMD.
Results
Participants characteristics at baseline
For the intervention groups, a total of 100 volunteers underwent randomization. Eligible par-
ticipants were symptomatic of MetS according to the biological tests on D1. Data were retained
for analyses only when complete data on primary and secondary outcomes were available.
Accordingly, complete data were available for 90 participants at baseline and 71 (79%) com-
pleted the whole intervention (Fig 1). No difference in descriptive characteristics, including
bones, was found between participants who dropped out of the program and those who com-
pleted it. No significant differences were observed in baseline bone parameters between groups
(Table 1). However, rE were younger and heavier than Re and had higher levels of vitamin D
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Fig 1. Flow chart of participants. re: moderate-resistance-moderate-endurance; Re: high-Resistance-moderate-endurance; rE: moderate-resistance-high-
Endurance.
doi:10.1371/journal.pone.0136491.g001
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than re and Re. No differences in baseline lumbar spine BMC and in BMD parameters were
observed between the sexes either within or between groups.
The control group (44 participants with no MetS parameters) was matched with the overall
MetS group for age and sex. No differences in bone variables between the controls and individ-
uals with MetS were found. However, controls were significantly taller than re and Re, with less
weight, total lean body mass, fat mass, and central fat mass than re, Re and rE. Controls also
had higher levels of vitamin D than re and Re and lower levels of C-reactive protein (CRP),
high-sensitivity CRP (hsCRP) and leptin than re, Re and rE (Table 1).
Cross-sectional MetS-related variation during follow-up
The descriptive characteristics for the re, Re and rE groups from D21 until D360 are presented
in Table 2. Cross sectional analyses revealed that at D21 Re had significantly lower body mass
than rE and less total body fat mass and central fat mass than re. Also, re had lower energy
intake than rE. At D90, remaintained significantly higher levels of total body fat and central fat
mass than Re. At D180, re had significantly lower energy intake, protein, vitamin D and leptin
than rE. At D360, re had higher total body fat mass than Re, while consuming less energy than
rE and less protein than Re and rE (Table 2).
There were no significant differences among MetS groups for BMC and BMD variables
throughout the duration of the study (Table 2). Also, no MetS group differed in bone mass and
bone density from controls (Fig 2).
Table 1. Baseline descriptive characteristics of the intervention groups and controls.
All i-groups i-groups P-value Control Control vs. i-groups
(n = 90) re (n = 33) Re (n = 30) rE (n = 27) i-groups (n = 44) P-value Post-hoc
Age (years) 60.50 ± 5.19 60.66±5.49 62.18±4.52 58.43±4.97 0.022 a 57.89±4.78 0.001 C < Re
Sex (F/M–n) 52/38 21/12 18/12 13/14 − 21/23 − −
Height (cm) 164.9 ± 8.6 163.8±8.9 163.5±6.7 167.9±9.7 0.106 170.2±8.0 0.001 C > re, Re
Weight (kg) 91.3 ± 13.0 91.4±12.7 87.1±11.8 95.9±13.4 0.037 a 69.2±12.1 <0.001 C < re, Re, rE
Total body lean mass (kg) 60.3 ± 10.9 58.8±11.2 58.7±10.1 64.0±11.1 0.117 50.8±11.0 <0.001 C < re, Re, rE
Total body fat mass (kg) 31.0 ± 7.8 32.5±7.6 28.4±7.7 31.9±7.7 0.080 16.1±3.9 <0.001 C < re, Re, rE
Central fat mass (kg) 3.1 ± 0.7 3.1±0.7 3.0±0.7 3.1±0.7 0.638 1.2±0.6 <0.001 C < re, Re, rE
Energy intake (KJ.d-1) 7590.9 ± 2105.4 7095.2±1643.0 7797.4±1869.9 7967.4±2728.1 0.227 − − −
Protein (g.d-1) 79.7 ± 21.0 73.7±16.6 80.3±18.3 86.4±26.4 0.063 − − −
Calcium (mg.d-1) 714.2 ± 296.4 661.4±193.8 781.4±360.4 704.0±317.5 0.272 − − −
Vitamin D (ng.ml-1) 16.93 ± 8.05 14.72±5.41 15.76±5.03 20.94±11.54 0.006 a,b 21.24±6.98 <0.001 C > re, Re
C-reactive protein (mg.l-1) 5.25 ± 3.42 6.06±4.07 4.54±2.83 5.04±3.02 0.197 3.06±0.74 <0.001 C < re, rE
hs C-reactive protein (mg.l-1) 4.57 ± 3.91 5.24±4.57 4.00±3.39 4.40±3.56 0.441 1.25±1.49 <0.001 C < re, Re, rE
Leptin (ng.dl-1) 3.06 ± 1.57 3.44±1.68 2.74±1.44 2.95±1.53 0.195 1.21±1.08 <0.001 C < re, Re, rE
Bone variables
Total body BMC (g) 2259.67 ± 392.57 2207.40±380.06 2229.05±381.93 2357.57±415.38 0.297 2356.07±459.52 0.291 −
Lumbar spine BMC (g) 67.05 ± 15.45 66.58±16.43 65.88±14.81 68.93±15.32 0.745 69.80±16.36 0.692 −
Femoral neck BMC (g) 4.27 ± 0.72 4.21±0.67 4.22±0.73 4.41±0.77 0.511 4.25±0.94 0.770 −
Total body BMD (g.cm-2) 1.13 ± 0.10 1.12±0.09 1.14±0.11 1.15±0.11 0.618 1.16±0.12 0.583 −
Lumbar spine BMD (g.cm-2) 1.05 ± 0.17 1.05±0.18 1.04±0.15 1.07±0.16 0.790 1.03±0.17 0.758 −
Femoral neck BMD (g.cm-2) 0.81 ± 0.11 0.82±0.11 0.79±0.12 0.83±0.11 0.411 0.78±0.14 0.234 −
Abbreviations: i-groups, intervention groups; re, moderate-resistance-moderate-endurance; Re, high-Resistance-moderate-endurance; rE, moderate-
resistance-high-Endurance; C, control; F, females; M, males; hs, high-sensitivity; BMC, bone mineral content; BMD, bone mineral density.
a Re significantly different than rE (P<0.05).
b re significantly different than rE. (P<0.05). re did not significantly differ from Re.
doi:10.1371/journal.pone.0136491.t001
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Table 2. Descriptive statistics of anthropometric, body composition, food intake, biochemical data and bone variables for the intervention groups,
from day 21 to day 360.
All i-groups i-groups P-value Post-hoc
(n = 325) re (n = 126) Re (n = 105) rE (n = 94)
Age (years)
D21 60.56±5.20 60.72±5.49 62.24±4.52 58.49±4.97 0.022 Re > rE
D90 60.78±5.21 61.04±5.53 62.17±4.47 58.76±5.09 0.057 −
D180 61.06±5.02 61.57±5.38 62.33±4.41 58.86±4.68 0.038 Re > rE
D360 61.69±4.88 61.82±5.51 63.48±3.81 59.41±4.16 0.026 Re > rE
Sex (F/M–n)
D21 52/38 21/12 18/12 13/14 − −
D90 48/35 21/11 14/12 13/12 − −
D180 48/33 21/10 15/12 12/11 − −
D360 39/32 20/10 11/11 8/11 − −
Compliance (Non-CP/CP–n)
D21 27/63 11/22 7/23 9/18 − −
D90 24/59 11/21 6/20 7/18 − −
D180 23/58 11/20 6/21 6/17 − −
D360 17/54 10/20 5/17 3/16 − −
Height (cm)
D21 165.2±8.9 163.9±8.9 164.1±7.6 168.0±9.8 0.143 −
D90 165.1±9.0 163.8±9.1 164.5±8.1 167.3±9.7 0.309 −
D180 164.7±8.6 163.0±8.0 164.5±7.9 167.3±9.8 0.188 −
D360 164.9±8.9 163.3±8.6 164.6±8.7 167.8±9.5 0.228 −
Weight (kg)
D21 87.9±12.3 88.2±12.1 83.7±11.3 92.0±12.4 0.037 Re < rE
D90 84.3±11.9 85.3±12.3 80.6±10.9 86.9±11.7 0.133 −
D180 84.5±12.7 84.9±12.6 81.7±12.4 87.2±13.2 0.311 −
D360 84.2±12.7 85.4±13.1 80.3±11.2 86.8±13.3 0.212 −
Total body lean mass (kg)
D21 59.5±10.5 57.8±10.7 58.3±9.7 62.9±10.6 0.130 −
D90 58.2±10.5 56.8±11.3 57.6±9.8 60.5±10.0 0.392 −
D180 58.4±10.3 56.6±10.8 58.3±9.9 61.1±10.0 0.285 −
D360 58.2±10.9 56.5±11.4 57.9±10.6 61.4±10.2 0.309 −
Total body fat mass (kg)
D21 28.3±7.5 30.3±7.4 25.4±7.2 29.1±7.4 0.027 re > Re
D90 26.1±7.3 28.5±6.8 22.9±7.4 26.4±7.0 0.015 re > Re
D180 26.0±8.1 28.3±6.8 23.4±8.6 26.1±8.3 0.067 −
D360 25.9±7.7 28.8±7.3 22.4±6.7 25.5±8.0 0.010 re > Re
Central fat mass (kg)
D21 2.7±0.6 2.9±0.6 2.5±0.6 2.7±0.6 0.016 re > Re
D90 2.5±0.6 2.7±0.6 2.2±0.5 2.4±0.6 0.036 re > Re
D180 2.4±0.7 2.6±0.7 2.2±0.8 2.3±0.7 0.105 −
D360 2.5±0.7 2.7±0.7 2.3±0.7 2.4±0.8 0.066 −
Energy intake (KJ.d-1)
D21 6534.0±511.4 6371.0±572.1 6516.4±512.6 6752.7±340.1 0.014 re < rE
D90 6704.4±1087.7 6510.0±961.7 6882.0±1257.2 6768.7±1054.6 0.411 −
D180 6673.0±965.5 6330.2±773.5 6831.9±1187.6 6948.6±794.4 0.036 re < rE
D360 6588.3±931.6 6390.0±821.7 6696.6±1073.7 6775.9±908.3 0.301 −
(Continued)
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Table 2. (Continued)
All i-groups i-groups P-value Post-hoc
(n = 325) re (n = 126) Re (n = 105) rE (n = 94)
Protein (g.d-1)
D21 101.6±11.1 99.1±11.7 100.7±11.3 105.5±9.1 0.070 −
D90 84.1±13.4 83.4±14.2 82.3±10.4 86.8±15.1 0.464 −
D180 82.2±14.9 76.2±16.3 81.9±12.4 90.7±11.7 0.001 re < rE
D360 81.2±10.6 78.8±10.7 79.2±10.5 87.3±8.3 0.011 re, Re < rE
Calcium (mg.d-1)
D21 830.2±103.7 835.1±98.1 830.3±100.4 824.2±116.7 0.922 −
D90 769.1±202.9 766.8±258.2 792.8±159.6 747.5±163.9 0.730 −
D180 811.3±137.3 788.0±140.0 802.8±141.8 852.8±124.3 0.214 −
D360 778.2±129.8 776.2±143.2 785.4±147.4 773.0±84.1 0.950 −
Vitamin D (ng.ml-1)
D21 21.53±17.13 19.29±10.19 18.49 ± 6.21 27.64±27.89 0.083 −
D90 18.92±10.62 18.88±12.20 17.40 ± 5.03 20.56±12.69 0.572 −
D180 19.31±9.33 15.56±4.30 21.52 ± 8.78 21.76±12.94 0.015 re < Re, rE
D360 21.12±6.76 20.07±7.29 20.64 ± 5.86 23.33±6.71 0.242 −
C-reactive protein (mg.l-1)
D21 4.35±3.09 4.86±3.22 3.67±3.11 4.47±2.88 0.308 −
D90 4.93±4.67 5.35±4.12 5.54±6.70 3.74±1.92 0.317 −
D180 4.15±2.32 4.61±2.83 3.85±1.99 3.89±1.84 0.384 −
D360 3.76±1.69 3.91±1.49 3.32±1.72 4.02±1.94 0.346 −
hs C-reactive protein (mg.l-1)
D21 3.17±3.66 3.86±4.15 2.48±3.64 3.10±2.95 0.331 −
D90 3.94±4.92 4.52±4.39 4.19±6.93 2.96±2.50 0.479 −
D180 2.87±2.67 3.19±3.13 2.33±1.98 3.08±2.73 0.431 −
D360 2.51±2.49 2.76±2.05 2.03±2.87 2.67±2.73 0.560 −
Leptin (ng.dl-1)
D21 2.41±1.78 2.69±1.37 2.19±2.05 2.31±1.90 0.513 −
D90 2.14±1.89 2.46±1.51 1.66±1.72 2.24±2.40 0.260 −
D180 2.33±1.89 3.00±1.86 2.14±2.06 1.63±1.46 0.024 re > rE
D360 1.96±1.34 2.28±1.41 1.81±1.33 1.65±1.20 0.226 −
Bone variables
Total body BMC (g)
D21 2267.54±391.68 2211.90±374.90 2234.42±369.07 2372.35±428.52 0.247 −
D90 2234.77±398.57 2196.47±393.54 2221.97±378.53 2297.09±432.77 0.633 −
D180 2227.28±387.18 2166.26±381.54 2208.52±372.50 2331.55±406.92 0.290 −
D360 2248.88±391.91 2181.22±383.08 2236.35±400.50 2370.22±387.97 0.258 −
Lumbar spine BMC (g)
D21 68.31±16.14 67.34±17.18 67.24±15.34 70.69±16.07 0.662 −
D90 67.95±16.33 68.22±17.30 66.53±15.30 69.09±16.64 0.852 −
D180 67.50±16.38 66.75±17.45 66.41±15.72 69.77±16.16 0.736 −
D360 67.98±16.40 66.14±17.58 67.10±16.24 71.92±14.76 0.469 −
Femoral neck BMC (g)
D21 4.32±0.77 4.22±0.74 4.28±0.73 4.51±0.85 0.326 −
D90 4.26±0.75 4.25±0.79 4.24±0.69 4.29±0.80 0.972 −
D180 4.27±0.74 4.25±0.78 4.19±0.70 4.40±0.75 0.581 −
(Continued)
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Cross-sectional effects of compliance
Compliance scores did not differ between groups. There was no difference between the diet
compliance score and the physical activity compliance score. Overall, compliance score was
71.7±7.2% in compliant participants and 34.4±15.2% in non-compliant participants. This
translates to an estimated 14.3±1.4 hours of physical activity in compliant participants and
6.8±3.0 in non-compliant participants.
Cross-sectional analyses of the compliance effects on BMC and BMD from D21 to D360 are
displayed in Figs 3 and 4, respectively. At D21, compliant re and Re participants had signifi-
cantly more lumbar spine BMC than their less-compliant re and Re peers. Similar findings
were observed in compliant Re participants for lumbar spine BMD. Non-compliant re partici-
pants also had lower lumbar spine BMC than controls. At D90 and D360, compliant re partici-
pants maintained significantly higher lumbar spine BMC than non-compliant re participants.
At D180 and D360, total body BMC and lumbar spine BMC were significantly lower in non-
compliant re participants than in controls. At the end of the intervention program, compliant
rE participants had greater femoral neck BMD than compliant Re participants and controls.
Longitudinal multilevel modeling analyses
Tables 3 and 4 summarize the results from multilevel models for BMC and BMD at the total
body, lumbar spine, and femoral neck. Total body BMC and BMD, lumbar spine BMC and
BMD, and femoral neck BMD changed significantly over baseline within individuals at each
measurement occasion. However, the three different modalities of exercise did not produce sig-
nificantly different effects on any BMC or BMDmeasurements. The significant contribution
of sex observed in five multilevel models indicates that female participants, regardless of the
Table 2. (Continued)
All i-groups i-groups P-value Post-hoc
(n = 325) re (n = 126) Re (n = 105) rE (n = 94)
D360 4.21±0.71 4.11±0.70 4.18±0.71 4.37±0.71 0.453 −
Total body BMD (g.cm-2)
D21 1.14±0.10 1.12±0.09 1.15±0.09 1.15±0.11 0.437 −
D90 1.14±0.10 1.12±0.09 1.14±0.10 1.15±0.11 0.540 −
D180 1.13±0.10 1.12±0.10 1.13±0.10 1.15±0.10 0.437 −
D360 1.14±0.10 1.12±0.10 1.14±0.11 1.17±0.11 0.412 −
Lumbar spine BMD (g.cm-2)
D21 1.06±0.17 1.05±0.19 1.05±0.15 1.08±0.17 0.729 −
D90 1.05±0.17 1.06±0.19 1.03±0.14 1.07±0.18 0.659 −
D180 1.05±0.17 1.05±0.20 1.03±0.15 1.08±0.16 0.497 −
D360 1.05±0.17 1.05±0.20 1.02±0.15 1.10±0.15 0.402 −
Femoral neck BMD (g.cm-2)
D21 0.81±0.12 0.82±0.12 0.80±0.12 0.84±0.12 0.363 −
D90 0.81±0.11 0.82±0.11 0.78±0.10 0.81±0.11 0.376 −
D180 0.80±0.11 0.82±0.12 0.78±0.09 0.82±0.11 0.247 −
D360 0.80±0.11 0.80±0.11 0.76±0.10 0.82±0.11 0.188 −
Abbreviations: i-groups, intervention groups; re, moderate-resistance-moderate-endurance; Re, high-Resistance-moderate-endurance; rE, moderate-
resistance-high-Endurance; C, control; M, males; F, females; Non-CP, non-compliant; CP, compliant; hs, high-sensitivity; BMC, bone mineral content;
BMD, bone mineral density.
doi:10.1371/journal.pone.0136491.t002
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MetS group, had significantly less total body BMC (-556.45±60.82 g), lumbar spine BMC
(-12.01±3.04 g) femoral neck BMC (-0.70±0.14 g), total body BMD (0.06±0.02 g.cm-2) and
femoral neck BMD (0.04±0.02 g.cm-2) than their respective male counterparts when other
confounders were controlled. An independent and significant increment of 8.14±3.27 g,
0.06±0.03 g.cm-2, and 0.04±0.02 g.cm-2 was also estimated for lumbar spine BMC, lumbar
Fig 2. Changes (360 days) on total body bonemineral content (BMC) and density (BMD), lumbar spine
BMC and BMD and femoral neck BMC and BMD for re, Re and rE groups. re: moderate-resistance-
moderate-endurance; Re: high-Resistance-moderate-endurance; rE: moderate-resistance-high-Endurance.
There were no significant differences in BMD and BMC parameters between re, Re and rE participants across
the intervention. Participants in the intervention did not have significantly greater or lower bone mass or
density development than controls.
doi:10.1371/journal.pone.0136491.g002
Multilevel Approach of a 1-Year Lifestyle Intervention on Bone in MetS
PLOS ONE | DOI:10.1371/journal.pone.0136491 September 16, 2015 12 / 20
spine BMD, and femoral neck BMD, respectively, for those participants who were compliant
with the exercise prescription throughout the intervention.
Once the longitudinal changes in anthropometry, biochemistry, and nutrition were
accounted for, total body BMC was observed to be negatively affected by the reduction of total
body lean mass, negative energy balance, and decreased leptin. Additionally, decreases in total
body fat mass contributed positively to total body BMC. Also, higher vitamin D significantly
and positively contributed to total body BMD. Decreases in total body lean mass and negative
energy balance significantly and independently contributed to decreases in lumbar spine BMC.
In contrast, vitamin D intake had a positive association with lumbar spine BMC and BMD.
Calcium intake and vitamin D were observed to be independent and significant predictors of
femoral neck BMC. In contrast, other nutrition factors did not significantly contribute to
observed variability within the changes in femoral neck BMD once age at baseline, sex, and
compliance were accounted for.
Fig 3. Compliance effect (360 days) on total body bonemineral content (BMC), lumbar spine BMC and femoral neck BMC for re, Re and rE groups.
re: moderate-resistance-moderate-endurance; Re: high-Resistance-moderate-endurance; rE: moderate-resistance-high-Endurance. *Compliant
participants significantly different from non-compliants (p<0.05). ‡ Non-compliant participants significantly different from controls.
doi:10.1371/journal.pone.0136491.g003
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Discussion
The major finding of the present study was that despite minimal effects of exercise modalities,
compliance with an intensive exercise program resulted in a significantly higher bone mass
during energy restriction than non-compliance. More specifically, when assessed cross-section-
ally, the effects of compliance on BMC and BMD was only noted during sporadic time points;
however to draw conclusions based on these cross sectional observations, we ignored nutrition
and other potential links to bone mass such as age, sex, anthropometry and compliance. When
BMC and BMD parameters were assessed longitudinally and the independent effects of size,
body composition, dietary intake and physical activity were accounted and individuals were
allowed to have their own regression lines with separate intercepts and slope coefficients, an
independent and significant increment of about 12%, 6% and 5% was noted for lumbar spine
BMC, lumbar spine BMD and femoral neck BMD, respectively, for participants compliant
with the exercise prescription across the intervention, whereas no changes were observed in
less compliant participants.
Fig 4. Compliance effect (360 days) on total body bonemineral density (BMD), lumbar spine BMD and
femoral neck BMD for re, Re and rE groups. re: moderate-resistance-moderate-endurance; Re: high-
Resistance-moderate-endurance; rE: moderate-resistance-high-Endurance. *Compliant participants
significantly different from non-compliants (p<0.05).
doi:10.1371/journal.pone.0136491.g004
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Effects of intervention and training modalities
Despite resistance training previously demonstrating increases in BMD at hip and lumbar
spine sites [31], the results of the current study did not demonstrate differences in bone param-
eters related to modalities of exercise. The high volume of prescribed resistance training in all
groups of physical activity (4 times a week i.e. 6 hours per week in our study) may explain the
absence of differences in the results. In the present study, despite a rapid and sustainable weight
loss in MetS participants, the BMC and BMD did not differ from controls. Despite that the
amount of weight loss observed in participants in the present study had previously been associ-
ated with decreases in BMD and BMC [32,33,34], our data support that energy restriction did
not necessarily result in bone loss [4,5,6,7]. The dose-response effect of exercise on bone is well
established [35] and may explain this absence of bone loss, as demonstrated in comparisons
between compliant and non-compliant participants.
Table 3. Multilevel regression analysis of total body, lumber spine and femoral neck bonemineral content (BMC) aligned by days from study
entry.
BMC
Total body Lumbar spine Femoral neck
Fixed explanatory variables Estimates Estimates Estimates
Constant 2073.2730±43.1213 69.3464±3.0431 3.8773±0.1015
Days from start -0.2123±0.0654 0.0019±0.0030 0.0002±0.0002
Days from start 2 0.0004±0.0002 -0.000005±0.000008 -0.000001±0.0000006
Age at study start NS NS NS
re vs Re NS NS NS
re vs rE NS NS NS
Female vs male 556.4508±60.8164 12.0111±3.0409 0.6962±0.1360
Non-compliant vs compliant NS 8.1360±3.2744 NS
Changes in total body lean mass -0.0068± 0.0019 -0.0003± 0.0001 NS
Changes in total body fat mass 0.0030±0.0012 NS NS
Changes in central fat mass NS NS NS
Energy intake -0.0044±0.0020 -0.0002±0.0001 NS
Protein NS NS NS
Calcium NS NS 0.0001±0.00005
Vitamin D NS 0.0020±0.0009 0.0019±0.0009
C-reactive protein NS NS NS
high-sensitivity C-reactive protein NS NS NS
Leptin -0.0004±0.0002 NS NS




Constant Days from start Constant Days from start
Level 1 (within individuals)
Constant 1276.48±114.44 3.48±0.31 0.0307±0.0652














Abbreviations: re, moderate-resistance-moderate-endurance; Re, high-Resistance-moderate-endurance; rE, moderate-resistance-high-Endurance.
Fixed effect values are presented as estimated mean coefficients ± SEE (standard error of estimate) of BMC in grams. Random effects values presented
as estimated mean variance ± SEE (BMC) in grams2. Days from start was centered around 180 days. Changes in total body lean mass, total body fat
mass and central fat mass (g) from study entry.
doi:10.1371/journal.pone.0136491.t003
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Effects of compliance
In our study, compliant participants increased BMC and BMDmore than non-compliant
participants, independent of the training groups. Thus, compliance appeared to be the most
predominant factor for maximizing bone benefits [22]. Factors affecting compliance are
numerous and should be taken into account in lifestyle interventions [36]. We report that all
sites (total body, lumbar spine and femoral neck, for both BMC and BMD) in compliant partic-
ipants benefited from the training, whereas previous literature has commonly reported site-
specific improvements [37,38]. This could be due to the high level of physical activity (15–20
hours/week) imposed on individuals who were sedentary at baseline, with resistance training
Table 4. Multilevel regression analysis of total body, lumber spine and femoral neck bonemineral density (BMD) aligned by days from baseline.
BMD
Total body Lumbar spine Femoral neck
Fixed explanatory variables Estimates Estimates Estimates
Constant 1.1119±0.0138 1.0956±0.0319 1.0727±0.1260
Days from start -0.000015±0.000006 -0.000005±0.0000011 -0.000047±0.000008
Days from start 2 NS NS NS
Age at study start NS NS -0.0041± 0.000209
re vs Re NS NS NS
re vs rE NS NS NS
Female vs male 0.0608±0.0201 NS 0.0440±0.0215
Non-compliant vs compliant NS 0.0618±0.0280 0.0415±0.0203
Changes in total body lean
mass
NS NS NS
Changes in total body fat
mass
- 0.0000011±0.0000003 NS NS
Changes in central fat mass NS NS NS
Energy intake NS NS NS
Protein NS NS NS
Calcium NS NS NS
Vitamin D 0.00014±0.00005 0.00022±0.00010 NS




Leptin -0.0000002±0.0000001 NS NS
Variance-covariance matrix of
random variables
Constant Days from start Constant Days from start Constant Days from start


























Abbreviations: re, moderate-resistance-moderate-endurance; Re, high-Resistance-moderate-endurance; rE, moderate-resistance-high-Endurance.
Fixed effect values are presented as estimated mean coefficients ± SEE (standard error of estimate) of BMD in g.cm-2. Random effects values presented
as estimated mean variance ± SEE (BMD in g.cm-2)2. Days from start was centered around 180 days. Changes in total body lean mass, total body fat
mass and central fat mass (g) from study entry.
doi:10.1371/journal.pone.0136491.t004
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stimulating all parts of the body. However, it also demonstrates that our relatively high-volume
training had no catabolic effect on bone metabolism, as encountered in overtraining [39].
Moreover, some bone parameters improved as acutely at the end of the residential program
which reinforces the immediate potential benefits of physical activity [7,19,20]. As the resorp-
tion phase of bone modelling lasts 2–3 weeks and the formation phase 2–3 months [40], it
would be surprising to have an increase in BMD and BMC after only three weeks of physical
activity. However, such data have been previously reported on individuals with MetS [41].
Moreover, it has been shown that individuals with fractures may achieve a significant increase
in BMC and BMD after three weeks [42].
Other explaining variables
In the current study, caloric restriction decreased BMC, in agreement with previous studies
[2,3]. We confirmed the importance of adequate sources of calcium [43,44] and vitamin D [45]
on BMC and BMD with a multilevel approach. Then, we demonstrated that lean body mass,
fat mass and leptin contributed to the prediction of changes in bone parameters. Fat tissue is
an active endocrine organ secreting a host of molecules called adipokines, such as leptin. We
have demonstrated the likelihood of bone-adiposity cross-talk in a recent literature review
[46]. We were unable to report that insulin, pro-inflammatory cytokines, adiponectin, PAI-1,
nor even bone metabolism markers were predictor variables of weight loss. Even if these factors
have previously been linked to BMC and BMD [43], other studies have not taken into account
repeated measurements, variations in the correlations over time, and the time difference
between measurements. Nevertheless, throughout the one-year intervention, females showed
fewer BMC and BMD benefits from physical activity than males. Even if being a male has a
positive effect on BMD [44], we report more extensive monitoring of gender differences in
BMC and BMD changes throughout a long-term intervention program than previously
published.
Limitations
This study has some limitations. A MetS group without any intervention or physical activity
could have provided opportunities to distinguish the effects of a total intervention or physical
activity from the diet. Implementing our intervention into health practices could be costly and
our high volume training protocol (15–20 hours per week) may be difficult to comply with
under non-supervised, community-based circumstances. However, we demonstrated the feasi-
bility of such training volumes in a large sample size of sedentary obese individuals over 50
years old. The absence of direct bone metabolism measurements could also be seen as a limita-
tion. Bone geometric data was not included in the current study. Eventually, despite some non-
significant results, the multilevel hierarchical approach highlighted the effects of physical activ-
ity compliance on the prevention of bone loss classically associated with weight loss. However,
compliance could only be judged at posteriori because a randomization based on compliance
lacks predictability. Further studies should focus on psychological factors aimed at improving
compliance in such long-term community-based intervention.
Conclusion
Changes in bone parameters did not relate to the modalities of exercise. However, independent
of physical activity groups, compliance with an intensive exercise program resulted in a signifi-
cantly higher bone mass during energy restriction than non-compliance. Exercise is therefore
beneficial to bone in the context of a weight loss program. Further studies should focus on
maximising compliance in such long-term community-based interventions.
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